Skip to main content

Vyome Holdings, Inc

HIND
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001427570

No open-market purchases or sales by Vyome Holdings, Inc insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $296.5K in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Vyome Holdings, Inc changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of HIND: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders015+15
Shares01.05M+1.05M
Value$0$5.23M+$5.23M

New holders (15)

Institutions that held Vyome Holdings, Inc at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to HIND in Q2 2021
InstitutionSharesValue% of portfolio
Armistice Capital, LLC816,527$4.08M0.11%
State Street Corp109,999$550.0K0.00%
Vanguard Group Inc51,120$256.0K0.00%
Jane Street Group, LLC24,188$121.0K0.00%
Geode Capital Management, LLC23,277$116.0K0.00%
Alpine Global Management, LLC17,000$85.0K0.01%
UBS Group AG2,831$14.0K0.00%
Advisor Group Holdings, Inc.1,294$6.00K0.00%
Citigroup Inc167$1.00K0.00%
Group One Trading, L.P.112$1.00K0.00%
JPMorgan Chase & Co2$00.00%
Wells Fargo & Company18$00.00%
Salem Investment Counselors Inc4$00.00%
Morgan Stanley4$00.00%
Tower Research Capital LLC (TRC)75$00.00%

Sold out (0)

Institutions that held Vyome Holdings, Inc at the end of Q1 2021 and filed for Q2 2021 without it.

None.